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Gene Targeting Turns Mice into 
Long-Distance Runners 
DOI: 10.1371/journal.pbio.0020322
Have you ever noticed that long-
distance runners and sprinters seem 
specially engineered for their 
sports? One’s built for distance, 
the other speed. The ability to 
generate quick bursts of power or 
sustain long periods of exertion 
depends primarily on your muscle 
ﬁ  ber type ratio (muscle cells are 
called ﬁ  bers), which depends on 
your genes. To this extent, elite 
athletes are born, not made. 
No matter how hard you train 
or how many performance-
enhancing drugs you take, if 
you’re not blessed with the muscle 
composition of a sprinter, you’re 
not going to break the 100-meter 
world record in your lifetime. (In 
case you’d like to try, that’s 9.78 
seconds for a man and 10.49 
seconds for a woman.)
Of course that doesn’t prevent 
those at the highest levels from 
using the latest performance enhancer 
to get that extra 1% edge. But wait 
until trainers hear about the Marathon 
Mouse. A new study by Ronald Evans 
and colleagues provides evidence that 
endurance and running performance 
can be dramatically enhanced through 
genetic manipulation.
Skeletal muscles come in two basic 
types: type I, or slow twitch, and type 
II, or fast twitch. Slow-twitch ﬁ  bers rely 
on oxidative (aerobic) metabolism 
and have abundant mitochondria that 
generate the stable, long-lasting supplies 
of adenosine triphosphate, or ATP, 
needed for long distance. (For more on 
muscle ﬁ  ber metabolism, see synopsis 
titled “A Skeletal Muscle Protein That 
Regulates Endurance”) Fast-twitch ﬁ  bers, 
which produce ATP through anaerobic 
glycolysis, generate rapid, powerful 
contractions but fatigue easily. Top-ﬂ  ight 
sprinters have up to 80% type II ﬁ  bers 
while long-distance runners have up to 
90% type I ﬁ  bers. Coach potatoes have 
about the same percentage of both. 
Endurance training can enhance the 
metabolic performance of muscle types, 
and now it appears that training can also 
induce conversion between ﬁ  ber types. 
Speciﬁ  c changes in gene expression 
trigger this oxidative ﬁ  ber transformation, 
but the transcription factor responsible 
for engineering this shift was unknown. 
Evans and colleagues suspected that a 
nuclear receptor called PPARδ—a major 
regulator of fat burning in fat tissue that 
is also prevalent in skeletal muscle—
might be involved. 
To investigate this possibility, the 
authors genetically engineered mice 
to express an activated form of the 
PPARδ protein in skeletal muscle. Type 
I ﬁ  bers normally express higher levels 
of PPARδ than type II ﬁ  bers, and the 
transgenic mice showed much higher 
levels of the protein than their normal 
littermates. The transgenic mice also 
had much redder muscles than the 
controls—type I ﬁ  bers have high levels 
of myoglobin, the red-pigmented 
protein that facilitates the movement 
of oxygen within muscle—and elevated 
levels of proteins associated with 
mitochondrial biogenesis and operation. 
A ﬁ  nal line of evidence indicating a type 
I ﬁ  ber switch was the elevated level of 
specialized type I contractile proteins 
and decreased level of specialized type 
II contractile proteins in the transgenic 
mice. Interestingly, these same results 
were seen when naturally occurring 
(endogenous) PPARδ levels were 
stimulated in the normal mice (with 
an orally active compound). 
This suggests that muscle ﬁ  bers 
can be transformed into type 
I endurance ﬁ  bers by simply 
activating the endogenous PPARδ 
pathway.
In a weight-conscious world, 
oxidative ﬁ  bers are thought to 
offer resistance against obesity 
since obese individuals have 
fewer type I ﬁ  bers than average-
weight individuals. Sure enough, 
transgenic mice fed a high-fat 
diet gained far less weight than 
normal mice fed the same diet, 
even in the absence of exercise. 
The transgenic mice had much 
smaller fat cells, which the authors 
attribute to enhanced oxidative 
capacity of the muscle tissue, 
and improved glucose tolerance. 
(Obese individuals lose the ability 
to metabolize glucose, which puts them 
at risk for diabetes.) But what about 
performance? Remarkably, the marathon 
mice ran about an hour longer than 
controls, showing dramatic improvement 
in both running time and distance—
increases of 67% and 92%, respectively.
Altogether, these results show that 
PPARδ drives the conversion of type I 
muscle ﬁ  bers by activating pathways 
that enhance physical performance and 
protect against obesity. The ﬁ  nding that 
endurance and running capacity can be 
genetically manipulated suggests that 
muscle tissue is far more adaptable than 
previously thought. Maybe Olympiads 
can be made after all—but don’t give up 
on training just yet. A full understanding 
of the molecular basis of muscle ﬁ  ber 
determination, including the interactions 
between PPARδ and its regulatory 
components, awaits further study.
Wang YX, Zhang CL, Yu RT, Cho HK, 
Nelson MC, et al. (2004) Regulation of 
muscle ﬁ  ber type and running endurance by 
PPARδ. DOI: 10.1371/journal.pbio.0020294
DOI: 10.1371/journal.pbio.0020322.g001PLoS Biology  |  www.plosbiology.org 1497
A Novel Pathway for a Tumor 
Suppressor
DOI: 10.1371/journal.pbio.0020339
Millions of different proteins exist in 
nature, each with a unique structure 
that determines its function. Proteins 
can have different effects depending 
on where they are in the cell and which 
proteins or pathways they associate 
with. The number of proteins produced 
by a cell varies, but scientists estimate 
that the human genome produces some 
100,000 proteins, and with thousands 
of proteins likely to be active in a single 
cell, it’s inevitable that the molecular 
components of cellular pathways 
overlap. It is thought that this may be 
the case for a tumor suppressor named 
VHL (after its role in von Hippel-Lindau 
disease, an inherited cancer syndrome 
that predisposes affected individuals to 
kidney and vascular tumors). 
The broad strokes of VHL action have 
been outlined: VHL is a ubiquitin ligase, 
an enzyme that targets proteins for 
destruction. VHL’s best characterized 
target is a transcription factor called 
hypoxia-inducible factor 1 (HIF-1). When 
oxygen levels drop below normal—a 
condition called hypoxia—HIF-1 
proteins are not degraded and may 
enter the nucleus, where they trigger 
the transcription of roughly 100 genes 
whose proteins either increase oxygen 
delivery or engage metabolic pathways 
that help the cell adapt to hypoxia. 
Scientists have long suspected that VHL 
has other targets, yet only HIF-1 has been 
clearly established. Now Peter Ratcliffe 
and colleagues use genetic methods in 
the nematode Caenorhabditis elegans 
to provide direct evidence of a HIF-1-
independent function of VHL.
Previous studies have shown that 
when cells lack VHL proteins, HIF-1 is not 
DOI: 10.1371/journal.pbio.0020339.g001
Genetic evidence for HIF-independent 
VHL-regulated pathways
A Skeletal Muscle Protein That Regulates Endurance
DOI: 10.1371/journal.pbio.0020315
It’s a common runner’s complaint. Just when you’ve built up enough strength and 
endurance to make running fun, those niggling aches and pains won’t go away. Every 
time your foot hits the ground, a force equal to about twice your weight shoots through 
your body, eventually chipping away at bones, cartilage, muscles, tendons, ligaments, 
and joints. For those lucky souls who can take the pounding, the main limitation to 
running performance stems from muscle fatigue. Now, Randall Johnson and colleagues 
report that a protein found in skeletal muscle profoundly inﬂ  uences muscle endurance.
Running, like any sustained skeletal muscle activity, consumes large quantities of 
adenosine triphosphate (ATP), a molecule that fuels many essential cell processes. A 
number of metabolic pathways supply muscle tissue with the ATP needed to power 
muscle contraction and sustain ongoing exercise. Which pathway predominates 
depends on factors like speed, duration, and type of activity, as well as on the 
availability of oxygen, which ﬂ  uctuates during activity. (For more on muscle cell type 
and endurance, see the synopsis titled “Gene Targeting Turns Mice Into Long-Distance 
Runners.”)
Say you start a half-hour run with a sprint. Within a few seconds, your body uses up the 
oxygen in its muscles and has to switch to anaerobic pathways, which metabolize sugars 
and fats to regenerate ATP. Aerobic pathways operate inside mitochondria, the cell’s 
major power generators. Anaerobic pathways like glycolysis function in the cytoplasm.
Hypoxia (the physiological state that occurs when oxygen levels drop below normal 
levels) governs how ATP is recycled and which energy-producing substrates (for 
example, glucose or fatty acids) are used; it also generates metabolic by-products, like 
lactic acid, during strenuous exercise. (Runners know the “lactic acid burn” associated 
with reduced blood pH.) Glycolysis—the primary source of anaerobic energy in 
animals—uses glucose, stored as glycogen in muscle cells, to produce ATP. When blood 
oxygen levels drop, the gene transcription factor hypoxia-inducible factor 1α (HIF-1α) 
triggers the glycolytic pathway. 
To understand how HIF-1α regulates skeletal muscle function, Johnson’s team 
generated mice that couldn’t express HIF-1α in skeletal muscle. Normal and mutant 
mice went through exercise routines that included swimming and running on treadmills. 
After exercise, the normal mice had increased levels of gene transcripts and enzymes 
involved in glucose transport and metabolism. In the mutant mice, expression of these 
glycolysis-associated genes and enzymes was signiﬁ  cantly lower. The mutants’ ATP 
levels, however, were normal. Without the molecular machinery to engage anaerobic 
metabolism, their muscles switched to aerobic pathways. The presence of enzymes that 
respond to reduced ATP levels by increasing mitochondrial ATP production, combined 
with low levels of lactic acid, conﬁ  rmed the switch. 
During endurance tests, the mutants could swim and run uphill (on treadmills tilted 
upward) longer than the normal mice, but when it came to running downhill, the normal 
mice prevailed. Downhill running, it turns out, favors glycolytic metabolism; uphill 
running and swimming favor oxidative pathways, which the mutants were predisposed 
toward. But their inappropriate use of this pathway came at a cost. By the ﬁ  nal day of 
a four-day exercise routine, the mutants’ run time was signiﬁ  cantly shorter and their 
muscles were clearly damaged. 
The mutants displayed a number of the trademark muscle defects seen in human 
patients with glycolytic processing disorders. These patients often have reduced lactate 
levels and elevated levels of mitochondrial enzymes, which apparently can cause a 
second wind and enhance endurance. This inappropriate use of oxidative pathways—
which compensates for the inability to trigger glycolysis—may account for the exercise-
induced muscle damage associated with these diseases. 
These results demonstrate that losing the molecular wherewithal to engage hypoxia 
response pathways has serious consequences for muscle function during exercise; it can 
give increased endurance, but at a high price. The mouse model presented here will help 
researchers explore how muscles normally function in response to low oxygen and how 
metabolic deﬁ  ciencies cause debilitating muscle disease. 
Mason SD, Howlett RA, Kim MJ, Olfert M, Hogan MC, et al. (2004) Loss of skeletal muscle 
HIF-1α results in altered exercise endurance. DOI: 10.1371/journal.pbio.0020288
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degraded, resulting in the overexpression 
of HIF target genes. VHL-defective 
cells also show abnormalities in the 
extracellular matrix, the structural 
scaffolding that surrounds the cell. But 
it has not been clear whether these 
effects stem from HIF-1 dysregulation or 
something else. 
To disentangle the actions of the 
two proteins, Ratcliffe and colleagues 
compared the consequences of VHL 
protein inactivation in a variety of genetic 
backgrounds in C. elegans. Then they 
analyzed the gene expression proﬁ  les of 
each of these mutant strains to identify 
pathways that required VHL but not HIF-1. 
To their surprise, the authors found, “all of 
the VHL-regulated genes fell into one of 
two patterns.” Their expression was either 
independent of HIF-1 and dependent 
on a range of genes associated with the 
extracellular matrix, or vice versa. What’s 
more, these gene sets fell into distinct 
categories based on their chromosomal 
location, predicted functional similarities, 
and pattern of dysregulation. 
These results, Ratcliffe and colleagues 
conclude, reﬂ  ect the disruption of 
“two discrete aspects of VHL function.” 
One depends on HIF-1—inhibiting 
the transcription factor when oxygen 
concentrations are normal—and 
one doesn’t; disruption of this HIF-1-
independent function produces defects 
similar to those seen in mutants with 
defects in extracellular matrix assembly. 
These results also fall in line with other 
studies that have linked VHL deﬁ  ciency 
to extracellular matrix defects, though 
the precise link remains unclear. It’s 
also not clear whether this HIF-1-
independent function means that VHL is 
still functioning as a ubiquitin ligase but 
targeting a different substrate or whether 
it represents a completely different 
function of VHL. For now, direct evidence 
of a HIF-1-independent pathway for 
VHL charts a clear path for researchers 
interested in pinning down the functions 
of this undoubtedly multidimensional 
ubiquitin ligase. It also gives VHL 
syndrome researchers—who have long 
suspected that other functions of the 
VHL tumor suppressor play a role in the 
onset of the disease—a promising lead 
to explore.
Bishop T, Lau KW, Epstein ACR, Kim 
SK, Jiang M, et al. (2004) Genetic analysis 
of pathways regulated by the von Hippel-
Lindau tumor suppressor in Caenorhabditis 
elegans. DOI: 10.1371/journal.pbio.0020289
Key to Cholesterol’s Role in 
Nematode Development
DOI: 10.1371/journal.pbio.0020345 
Cholesterol has a bad rap for its 
association with human heart disease. But 
actually cholesterol and other sterols are 
essential for a wide variety of organisms. 
For most eukaryotes—organisms whose 
cells have nuclei—sterols reside in the 
cell membrane and play major structural 
roles. Sterols keep cell membranes 
ﬂ  exible, for example. These chemicals 
also hinder leakage of ions across the 
membrane, which is crucial in order 
for muscles to 
contract and 
nerves to conduct 
signals.
For the tiny 
(eukaryote) 
nematode worm 
Caenorhabditis 
elegans, sterols are 
a dietary staple. 
Worms can’t make 
these chemicals 
from scratch, just 
as humans can’t 
make vitamin C or the essential amino 
acids, so they have to harvest these 
chemicals from their surroundings. If 
nematodes hit hard times—they can’t 
ﬁ  nd enough sterols, say, or are starved 
or overcrowded—they can delay 
developing into adults. Instead, they enter 
a stage called a dauer in which they don’t 
eat and hardly move a muscle. In this 
state, they can persist several months—
many times their normal lifespan—and 
then revive when conditions improve.
Though C. elegans is extensively 
studied, there’s still controversy over 
the role of cholesterol in this organism. 
To develop into adults, the nematodes 
need only small amounts of cholesterol 
in their diet, suggesting cholesterol does 
not play a major role in their membranes. 
Instead, nematodes—like many other 
eukaryotes—might use cholesterol to 
make hormones, which are typically 
active at very low concentrations. Such 
hormones could play a key role in the 
worms’ development into either adults or 
dormant dauers. But no one had found 
any nematode hormones derived from 
cholesterol—until now.
In this issue of PLoS Biology, Teymuras 
Kurzchalia and colleagues show 
deﬁ  nitively that cholesterol does not play 
an essential structural role in C. elegans. 
Rather, cholesterol is the precursor for a 
hormone—or set of hormones—key in 
the worms’ development into adulthood 
and thus key for reproduction. The 
researchers have partially puriﬁ  ed this 
cholesterol derivative and named it 
gamravali, from the Georgian word for 
reproduction, “gamravleba.”
When on sterol-free diets, all larvae 
showed arrested development, becoming 
dormant dauers. But, surprisingly, the 
concentration of cholesterol they needed 
to develop into adults was miniscule, 
around 20 nanomoles. When given 
scant amounts of cholesterol, the worms 
converted some of it to a sterol called 
lophenol. The researchers found, however, 
that supplementing a sterol-free diet with 
lophenol was not 
enough to sustain 
development 
into adulthood. 
Apparently the 
worms need 
cholesterol, which is 
fed into two distinct 
pathways: one 
makes lophenol and 
another makes the 
hormone gamravali.
The researchers 
have only 
partially puriﬁ  ed gamravali, so they 
don’t yet know its molecular weight 
or composition or even whether it is a 
single molecule. But by working with 
mutant worms, they have begun to pin 
down where gamravali acts in the worms’ 
developmental pathway. One mutant C. 
elegans line, for instance, was unfazed by 
the cholesterol-free diet. These mutants 
were missing the daf-12 gene, one 
of a set of genes crucial in nematode 
development and aging. On the 
cholesterol-free, lophenol-supplemented 
diet, these mutants developed into 
normal adults. Other mutant lines that 
each lacked one of several other daf 
genes, however, developed into dauers 
when deprived of cholesterol. In this way 
the researchers found where gamravali 
acts in the worms’ developmental 
pathway: the hormone gamravali likely 
comes into play before daf-12, but after 
the other daf genes. Kurzchalia and 
colleagues are currently working to 
further purify gamravali and identify 
exactly how it gives cholesterol such a 
crucial role in the worms’ lifecycle.
Matyash V, Entchev EV, Mende F, Wilsch-
Bräuninger M, Thiele C, et al. (2004) 
Sterol-derived hormone(s) controls entry 
into diapause in Caenorhabditis elegans by 
consecutive activation of DAF-12 and DAF-
16. DOI: 10.1371/journal.pbio.0020280
DOI: 10.1371/journal.pbio.0020345.g001
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A Mechanism of Prion Propagation
DOI: 10.1371/journal.pbio.0020360 
The key to any protein’s function is its structure. Proteins 
ﬁ  rst emerge as a linear strip of amino acids from the cellular 
protein-manufacturing machinery, and it is this primary 
sequence that determines a protein’s ultimate conformation. 
Improperly folded proteins—which can gum up cells and, 
when secreted, tissues—are normally destroyed. But in a 
wide range of diseases, including prion (from proteinaceous 
and infectious) diseases and neurodegenerative diseases 
like Parkinson disease and Alzheimer disease, amyloid 
ﬁ  brils, or plaques—misshapen proteins that aggregate 
into characteristic rope-like conﬁ  gurations—accumulate in 
tissue. 
When amyloid precursors and prions (pronounced 
PREE-ons) lose their normal conformation, they acquire the 
ability to infect their neighbors. Like molecular dominoes, 
the fall of one malformed protein precipitates the downfall 
of its neighbors, as one protein after another assumes the 
misshapen form of the ﬁ  rst. Any chance of developing 
methods to contain the expansionist tendencies of these 
proteins depends on understanding the mechanism of 
propagation, an area of active research. 
An abundance of small protein aggregates, called 
oligomers, is associated with amyloid ﬁ  ber growth and 
formation. (Single proteins are called monomers; they 
“polymerize” into longer chains.) Mounting evidence 
suggests these so-called amyloid intermediates are the 
“toxic species” underlying amyloid diseases. The steps in 
amyloid formation, however, are unclear: Must amyloids 
follow a progression from monomer to oligomer to 
plaque? That is, are oligomers required for amyloid plaque 
formation? Using the yeast prion protein Sup35 to study 
how amyloids form, Jonathan Weissman and colleagues 
propose a model of amyloid plaque formation and show 
that it can indeed occur in the absence of the putative toxic 
oligomers. 
In yeast, the Sup35 protein forms self-replicating 
aggregations reminiscent of amyloid formation and prion 
propagation. Though yeast aren’t susceptible to prion 
diseases, they 
do assume what 
scientists call 
the yeast prion 
state. Two protein 
domains called 
NM together form 
self-propagating 
amyloid ﬁ  bers 
that give rise to 
the yeast prion 
state. Oligomers, 
which are typically 
seen when other 
proteins form 
amyloids, have also 
been seen during 
this process, some 
of them near NM 
DOI: 10.1371/journal.pbio.0020360.g001
Schematic of single-molecule 
ﬂ  uorescence experiment used to 
establish amyloids growth mechanism 
Keeping Proteins on Target
DOI: 10.1371/journal.pbio.0020361
To keep a cell healthy, proteins must go to the right places 
within a cell. To direct proteins to speciﬁ  c areas of the cell, 
they’re marked with tags akin to zip codes on mail. These tags 
can direct one protein to the cell’s nucleus, where it regulates 
gene expression, say, while another is sent to the hinterlands 
of the cell membrane, where it receives environmental signals. 
Protein targeting is crucial even as cells are building proteins—
otherwise, for example, proteins won’t fold into the proper shape.
There’s a pair of proteins that, across all organisms, plays a 
key role in protein targeting. Called Ffh and FtsY in bacteria, 
these proteins each have an active and inactive state; only when 
they’re in their active state can they bind each other and deliver 
other proteins to their proper location. Both these proteins are 
GTPases, a class of proteins that work as molecular switches. 
However, among GTPases, Ffh and FtsY are unique. Other 
GTPases switch between active and inactive states by binding 
different forms of a small, energy-carrying molecule—either GTP 
or GDP. Such GTPases often require the help of other proteins to 
switch states. Ffh and FtsY, on the other hand, almost always have 
GTP bound. And when they interact, they change each other’s 
state—allowing each other to convert GTP to GDP—without the 
help of other proteins. But researchers didn’t know exactly how 
these proteins interacted or how they switched between their 
active and inactive forms.
Now, as reported in this issue of PLoS Biology, Shu-ou Shan and 
colleagues have found that when Ffh and FtsY bind and then 
activate each other, they likely go through an unusual, multi-step 
process in which the proteins change shapes, ﬂ  exing so that 
different parts of the proteins become active at each step.
The researchers mutated 45 different sites in the gene that 
encodes the FtsY protein to produce a bevy of mutant proteins 
with different properties. The researchers chose mutations 
that produced amino acid substitutions at sites in the FtsY 
protein that have been preserved through evolution, and so are 
presumably crucial for the protein’s function. These sites, it turns 
out, are all on the protein’s surface where it interacts with Ffh.
The mutant versions of FtsY varied in how well they bound 
to the normal version of Ffh and how quickly the two proteins 
activated each other. The researchers were able to sort the 
different mutations into four different classes based on the type 
of problem the proteins had: some bound Ffh very loosely, some 
bound Ffh well but only weakly turned on its GTPase activity, 
and so on. All of these mutations would presumably foul up the 
protein targeting system, so this explains why certain amino 
acids have been preserved through evolution.
Both Ffh and FtsY change shapes as they bind, activate each 
other’s GTPase activity, then cleave GTP and release each other, 
the researchers infer. They don’t have direct evidence for these 
shape changes, but the postulated bends and twists during 
interaction are consistent with the build of the proteins. These 
shape changes, they speculate, could switch different parts of 
each protein between active and inactive states. By showing 
how this unique type of GTPase switch likely works, Shan and 
colleagues have helped explain how cells target proteins to 
speciﬁ  c areas—and perhaps have paved the way for others to 
ﬁ  nd similar switches elsewhere within cells. 
Shan S, Stroud RM, Walter P (2004) Mechanism of association 
and reciprocal activation of two GTPases. DOI: 10.1371/journal.
pbio.0020320
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ﬁ  ber ends. Weissman’s team wanted to 
know what these oligomers were doing. 
To investigate the role of oligomers in 
NM amyloid formation and growth, the 
researchers explored the relationship 
between monomer concentration and 
polymerization progress. Initially, ﬁ  ber 
growth rate was tied to the concentration 
of NM monomers; but as concentrations 
increased, growth rate was moderated by 
NM conformational changes caused after 
binding to the ﬁ  ber ends. Shaking the 
samples increased polymerization rate. 
During polymerization reactions, 
the authors observed a pronounced 
pause, followed by an abrupt increase 
in polymerization rate. Since the length 
of the pause showed only a weak 
dependence on the concentration of 
monomers, Weissman and colleagues 
explain, this ﬁ  nding could not be 
explained by a simple model of 
nucleation polymerization, in which 
growth occurs monomer by monomer, 
emerging from a monomer “nucleus.”
Instead, Weissman and colleagues’ 
ﬁ  ndings support a model in which 
nucleated monomers initially 
support ﬁ  ber growth, ﬁ  bers undergo 
fragmentation, and monomers rapidly 
grow from the broken ends. Weissman 
and colleagues conﬁ  rmed that the ﬁ  bers 
were growing monomer by monomer by 
attaching to fragmented ﬁ  ber ends with 
ﬂ  uorescent microscopy, which can detect 
single molecules. 
Though the authors do not rule out 
the possibility that oligomers could 
attach to the ﬁ  ber ends as well, their 
results show that amyloid growth can 
occur independently of oligomers. 
Since many of the properties observed 
in Sup35 polymerization are evident 
in other amyloid-forming proteins, the 
model presented here may be shared as 
well. Future studies will have to explore 
this question, along with the issues of 
how oligomers ﬁ  gure into the process 
and how they cause disease. Weissman 
and colleagues raise the possibility that 
creating conditions that favor ﬁ  ber growth 
while inhibiting oligomer formation might 
limit the toxic effects of amyloid plaques. 
The approaches outlined here should 
lay the foundation for exploring these 
questions in higher organisms. 
Collins SR, Douglass A, Vale RD, 
Weissman JS (2004) Mechanism of prion 
propagation: Amyloid growth occurs by 
monomer addition. DOI: 10.1371/journal.
pbio.0020321
Spotting Signs of Natural Selection
DOI: 10.1371/journal.pbio.0020344
Milk, cheese, and yogurt are so ingrained in the diets of Europeans that it’s easy 
to forget that their ancestors ever ate differently. But about 9,000 years ago, before 
the domestication of cows, sheep, and goats, milk was a staple only for babies. Back 
then—just as in most Asian and African cultures today—individuals lost their ability to 
digest lactose, a sugar found in milk, as they grew up.
But with the domestication of animals, milk became abundant. Among herders, 
individuals had an advantage if they had versions of genes, also known as alleles, that 
allowed them to digest lactose into adulthood. They would tend to be healthier and 
reproduce more than those who could not digest lactose. Thus, by natural selection 
within herding groups, over generations those who could drink milk into adulthood 
became more common.
Researchers have found the allele that allows adults to digest lactose, and it’s one of 
the clearest signs of natural selection in humans. In groups with a history of herding, the 
vast majority of people have the allele, whereas in non-herding groups, most people 
lack it. Researchers can ﬁ  nd such footprints of selection by comparing groups of people 
that have lived in different 
environments, for example, or 
have eaten different diets.
In this issue of PLoS Biology, 
Joshua Akey and colleagues 
report new-found signs of 
natural selection in several 
human genes—including 
a chunk of Chromosome 7 
encompassing four genes, the 
largest footprint of selection found yet. The research group analyzed the complete 
sequences of 132 genes in a set of 23 European-Americans and 24 African-Americans. All 
these genes are involved in inﬂ  ammation, blood clotting, or blood pressure regulation 
and were studied as part of a larger project looking for alleles that contribute to disease.
In general, solid evidence of natural selection acting on genes is hard to ﬁ  nd. The 
history of selection can be obscured by a variety of processes. For one, genes can 
undergo “neutral changes,” in which some of its base pairs change, but without altering 
the sequence or function of the protein the gene codes for. Also, idiosyncrasies in the 
history of a population can leave marks on the gene pool. A lineage can go through a 
“bottleneck,” for example, if a small group splinters off from a larger population and 
then later multiplies. In general, the splinter group won’t perfectly represent the larger 
population, so the frequencies of alleles for many genes will be skewed in the splinter 
group’s lineage. 
Having ﬁ  rst ruled out irrelevant changes in genes and population history effects, Akey 
and colleagues found strong signs of natural selection only in the European-Americans, 
suggesting this group went through signiﬁ  cant changes in climate, diet, or culture 
more recently than the African-American group. This ﬁ  ts with the well-accepted idea 
that European populations came from small groups that split off from the larger African 
population. The researchers ﬁ  nd evidence for such an event in the European population 
about 40,000 years ago. They also estimate that the region of Chromosome 7 was 
subjected to strong selection around 10,000 years ago, roughly when European herders 
began drinking milk. Interestingly, two of these genes, TRPV5 and TRPV6, limit the rate 
of calcium uptake, so selection on one or both of these genes in Europeans could have 
originated with herding.
Recent studies also found TRPV6 to be more active in prostate cancer cells. In addition, 
African-Americans suffer higher rates of prostate cancer, and Akey and colleagues 
found that European-Americans have alleles of TRPV6 different from those of African-
Americans. Given this evidence, the researchers suggest that this gene may be involved 
in susceptibility to prostate cancer. This research could therefore shed light on the 
evolution of complex diseases such as cancer and why different populations suffer 
different rates of disease. 
Akey JM, Eberle MA, Rieder MJ, Carlson CS, Shriver MD, et al. (2004) Population history 
and natural selection shape patterns of genetic variation in 132 genes. DOI: 10.1371/journal.
pbio.0020286
DOI: 10.1371/journal.pbio.0020344.g001
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Scientists continue to argue the 
extent that human activities drive global 
warming, but few would argue that it 
exists. The International Panel on Climate 
Change predicts that greenhouse gases 
will increase global temperatures by 3.6 
degrees F by 2100—a rise unprecedented 
over the past 10,000 years. What might 
the world look like as we approach that 
point? Wetlands will disappear. Floods, 
hurricanes, and droughts will become 
progressively more severe. Infectious 
diseases will increase in virulence and 
range. Montana’s famed glaciers may all 
but disappear within 30 years. A quarter 
of species may vanish by 2050. 
While the effects of climate change 
on species’ geographic ranges and 
population dynamics have been studied 
to some extent, scientists know little 
about how species respond to climate 
change at the genetic level. In this 
issue, Elizabeth Hadly and colleagues 
analyze three different dynamic 
processes—environmental change, 
population response, and gene diversity 
ﬂ  uctuations—and present evidence that 
climate change inﬂ  uences variation in 
genetic diversity.
Focusing on two mammal species—
the Montane vole and the northern 
pocket gopher—Hadly et al. asked how 
the two species responded to historical 
climate-induced habitat alterations in 
northwestern Wyoming. They gathered 
fossils from Yellowstone National Park’s 
Lamar Cave, which contains a treasure 
trove of carbon-dated deposits that 
mirror the community of mammals 
in the area today. Comparing genetic 
material extracted from fossil samples 
from different time points over the past 
3,000 years to genetic data taken from 
contemporary animals, Hadly’s team 
tracked genetic changes in populations 
of the two species and used this 
information (along with relative fossil 
abundance and modern population 
density) to estimate changes in effective 
population size over time. (Effective 
population size refers to the number of 
individuals contributing genetic material 
to the next generation. Populations 
with a small effective population size, 
for example, would be highly vulnerable 
to environmental catastrophe.) The 
genetic and demographic data were 
then combined with 
environmental records to 
analyze the relationship 
between the factors.
Studying these 
populations in space 
and time—an approach 
the authors call 
“phylochronology”—
offers an opportunity 
to analyze the genetic 
diversity of a species 
against the backdrop of 
environmental ﬂ  uctuation 
within an evolutionary 
time frame. It also suggests 
how microevolutionary 
forces—factors that 
affect genetic variation 
in populations over 
successive generations—
shape genetic responses 
to climate change. Such 
evolutionary forces include 
mutation, genetic drift (the 
random gene ﬂ  uctuation 
in small populations that 
stems from the vagaries of 
survival and reproduction), 
and gene ﬂ  ow (changes in the gene 
frequency of a population caused by 
migration). 
The past 3,000 years includes two 
periods marked by dramatic climate 
change—the Medieval Warm Period and 
the Little Ice Age—that had different 
effects on local mammal populations 
depending on their habitat preferences. 
Habitat specialists, the vole and pocket 
gopher live in the wet mountain regions 
of western North America. Though both 
showed population increases during 
wetter climates and declines during 
warmer periods, Hadly et al. predicted 
the gene diversity ﬂ  uctuations of the 
two species would differ based on their 
different ecological behaviors. And that’s 
what they found: genetic response is tied 
to population size. Pocket gophers have 
low population densities, stick close to 
home, and are ﬁ  ercely territorial, while 
voles live in high-density populations 
and range more widely. For the gophers, 
population declines resulted in reduced 
gene diversity; for the voles—which have 
a larger effective population size and 
greater dispersal between populations—
population declines resulted in increased 
gene diversity. But what forces underlie 
these differences in genetic variation?
A recent study suggests that migration 
(a primary agent of gene ﬂ  ow) is most 
common in and between low-density 
patches in vole populations, which 
implicates gene ﬂ  ow as the driver of 
gene diversity patterns. But the authors 
don’t rule out selection as a possibility, 
and suggest how to go about resolving 
the question. Hadly et al. show that 
phylochronology opens a unique window 
onto the relatively recent evolutionary 
past and offers “the potential to separate 
cause from effect.” They also conclude 
that “differences in species demography 
can produce differential genetic response 
to climate change, even when ecological 
response is similar.” With a 3-degree 
temperature increase in just the past 50 
years in the American West, conservation 
of biodiversity may well depend on such 
insights.
Hadly EA, Ramakrishnan U, Chan YL, van 
Tuinen M, O’Keefe K, et al. (2004) Genetic 
response to climatic change: Insights from 
ancient DNA and phylochronology. DOI: 
10.1371/journal.pbio.0020290
DOI: 10.1371/journal.pbio.0020338.g001
Do Genes Respond to Global Warming?
DOI: 10.1371/journal.pbio.0020338
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Natural Biodiversity Breaks Plant Yield Barriers
DOI: 10.1371/journal.pbio.0020331
The birth of agriculture, some 10,000 years ago in the Middle 
East’s Fertile Crescent, revolutionized human culture and society. 
Reﬁ  ned farming techniques led to increased yields and freed 
humans from the demands of constant foraging. Along with 
that freedom came social complexity, division of labor, improved 
standards of living, and a measure of leisure time. Agriculture 
also led to overpopulation followed by starvation, conﬂ  ict over 
fertile farming land, and environmental damage. For the Maya 
and other civilizations, such consequences proved fatal. 
Many consumer and environmental groups believe that 
modern industrial agricultural practices like factory farming 
of animals and genetic engineering of crops threaten to bring 
similar ruin. But with 6 billion people living on the planet—a 
ﬁ  gure that’s expected to increase 50% in just 50 years—many 
plant scientists believe that feeding a burgeoning population 
will require the tools of biotechnology. Plant breeders face the 
daunting challenge of developing high-yielding, nutritious crops 
that will improve the global quality of life without harming the 
environment or appropriating dwindling natural habitats for 
agricultural production. A major roadblock to feeding the world 
is a continuing decline in the genetic diversity of agricultural 
crops, which has in turn limited their yield improvement. 
(Domestication often involves inbreeding, which by deﬁ  nition 
restricts the gene pool.) Now Amit Gur and Dani Zamir of 
Hebrew University report a way to lift these productivity barriers 
by tapping into the natural diversity of wild plants.
Traditional plant breeders improve the quality and yield of 
crops by crossing plants with desired traits to create a new, 
hopefully improved, hybrid strain. But traditional breeding is 
limited by the available gene pool of a cultivated plant species 
and eventually hits a wall—reshufﬂ  ing the same genetic 
variation can boost yield only so much. With the advent of 
biotechnology, plant scientists were buoyed by the prospect of 
improving plants through genetic modiﬁ  cation. But aside from 
a few successes with introducing single-gene herbicide- and 
pest-resistant traits, most plant traits have proved too complex 
to repay the incorporation of a single transgene—that is, a gene 
taken from a different species—with the hoped-for response. 
Biotech-based investigations and applications in plant science 
have also been hampered by consumer reaction against 
genetically modiﬁ  ed organisms. (For more on the techniques of 
modern plant breeding, see the essay “Diversifying Selection in 
Plant Breeding,” also in this issue.)
Faced with these limitations, Gur and Zamir tried another 
approach—a back-to-nature approach. “Natural biodiversity 
is an unexploited sustainable resource that can enrich the 
genetic basis of cultivated plants,” they explain in the report. 
The distantly related wild cousins of cultivated plants can be 
seen as a “huge natural mutagenesis resource” with novel gene 
variants that can increase productivity, quality, and adaptability. 
Not only that, the genetic material of wild plants—every gene 
and regulatory element—has already been reﬁ  ned and tested by 
over a billion years of evolution and natural selection.
To identify genomic regions in wild tomato species that affect 
yield, Gur and Zamir created a population of hybrid crosses of 
a wild tomato species and a cultivated tomato species; each 
line had a single genomic region from the wild tomato inserted 
into the cultivated plant. Rather than introducing a single wild 
tomato gene into the cultivated plants, the authors used a 
“pyramided” strategy that combined three independent yield-
enhancing genomic regions from the wild species into the new 
plant line. Plants were grown over three seasons, during which 
they were exposed to different environments, including drought. 
By combining traditional phenotyping techniques—which 
characterize the plant’s physical traits based on its genetic 
makeup—with genetic marker analysis, the authors identiﬁ  ed a 
number of wild tomato genomic regions that increased yield. 
Their results demonstrate that an approach based on 
biodiversity—which takes advantage of the rich genetic variation 
inherent in wild relatives of cultivated crops—can produce 
varieties that outperform a commercially available hybrid tomato 
in both yield and drought resistance. Gur and Zamir attribute 
the improved performance to their unique pyramiding strategy. 
Their hybrid model—applying the tools of modern genomics 
to traditional plant breeding—offers plant breeders a powerful 
approach to improving the quality and yield of cultivated plants 
by taking advantage of the inherent biodiversity of the natural 
world. It’s a strategy that may well apply to rice, wheat, and other 
vital staples of the world’s food supply. 
Gur A, Zamir D (2004) Unused natural variation can lift yield barriers 
in plant breeding. DOI: 10.1371/journal.pbio.0020245
The Genome of a Methane-Loving Bacterium
DOI: 10.1371/journal.pbio.0020358
Mention greenhouse gases to most people and they’re apt to 
think of carbon dioxide, fossil fuels, and big cars. Though carbon 
dioxide emissions are the major source of greenhouse gases, 
methane is far more effective at trapping heat in the atmosphere. 
Like increasing carbon dioxide levels, rising levels of atmospheric 
methane have been attributed to human activity, mostly in the 
form of landﬁ  lls, natural gas and oil processing (about 60%), 
domesticated livestock (cattle account for about 75% of livestock 
contributions), and rice ﬁ  elds (up to 29% of total emissions).
Ruminants—from cows and water buffalo to llamas and 
vicunas—emit methane gas as a natural by-product of their 
digestive process, which confers a unique ability to digest 
cellulose. Ruminants don’t digest cellulose directly, but depend 
on a variety of microbes living in their rumen (main stomach) 
to do it for them. 
These microbes 
ferment cellulose, 
breaking it down into 
products the ruminant 
can digest. During 
this process, some 
microbes—bacteria 
called methanogens—
produce methane, 
which ruminants 
expel by eructation 
(otherwise known as 
belching). 
Luckily, there are 
microbes, called 
methanotrophs, that 
consume methane. A 
DOI: 10.1371/journal.pbio.0020358.g001
Methylococcus capsulatus cultured in 
the presence of a high concentration of 
copper  (Image: Anne Fjellbirkeland)
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Damage Response Protein Buys Time for 
Bacterial DNA Repair
DOI: 10.1371/journal.pbio.0020325
It is often said that after a nuclear catastrophe, cockroaches 
will inherit the earth, because they are so resistant to the harmful 
effects of ionizing radiation. But should the unthinkable come 
to pass, the bacterium Deinococcus radiodurans is likely to 
outlast even the cockroach. Its ability to endure radiation is truly 
impressive: it can withstand a dose a thousand times that which 
will kill a human. How it accomplishes this phenomenal feat of 
survival is the subject of a study in this issue by John Battista and 
colleagues at Louisiana State University in Baton Rouge and at 
the University of Wisconsin at Madison.
While radiation damages many cellular components, it is 
the fracturing of the cell’s DNA that is the most harmful. DNA 
breaks can be repaired, but in doing so, the cell is racing against 
time. The exposed free ends of the DNA invite digestion by 
the cell’s own enzymes, called exonucleases. If the DNA is not 
stitched back together quickly enough, the exonucleases will 
degrade it past the point of repair, and the cell will ultimately 
succumb. Large doses of radiation can fracture a chromosome 
in thousands of places, far in excess of the repair ability of most 
cells. D. radiodurans, however, largely prevents exonuclease 
digestion, an ability which has previously been shown to be 
linked to the activity of a gene with the rather uninformative 
name of DR0423. But how, exactly, does this gene accomplish this 
life-saving feat?
To answer this question, Battista and colleagues ﬁ  rst showed 
that, following radiation exposure, DR0423 was upregulated 20- 
to 30-fold, and that deletion of the gene renders D. radiodurans 
susceptible to ionizing radiation. Together, these results clearly 
indicate that the DR0423 gene product is critical for protecting 
the bacterium. 
Based on this, they 
dubbed the gene 
ddrA, for “DNA 
damage response.” 
They also found 
that DdrA, the 
protein encoded 
by ddrA, binds to 
single-stranded 
fragments of 
DNA, exactly like 
those found at the 
broken ends of the 
DNA double helix 
when damaged by 
radiation. Finally, 
they showed that 
when DdrA bound to these broken ends, they were protected 
from digestion by exonucleases. 
An important question about this system is what it is actually 
good for. Since the level of radiation tolerated by the bacterium 
is found nowhere on earth, of what use is such an efﬁ  cient DNA 
protection system? The answer might be that it also protects D. 
radiodurans from the effects of desiccation, a condition much 
more common in the life of a bacterium, and one which also 
induces widespread DNA damage. While ddrA cannot prevent 
the damage, it can preserve the DNA from degradation until 
conditions once again allow the bacterium to function, and 
repair its DNA. 
Harris DR, Tanaka M, Saveliev SV, Jolivet E, Earl AM, et al. (2004) 
Preserving genome integrity: The DdrA protein of Deinococcus 
radiodurans R1. DOI: 10.1371/journal.pbio.0020304
DOI: 10.1371/journal.pbio.0020325.g001
D. radiodurans R1
type of aerobic bacteria, methanotrophs 
oxidize methane as an energy and carbon 
source using the enzyme methane 
monooxygenase. They’ve been found in 
soils, landﬁ  lls, sediments, hotsprings, and 
peat bogs, among other environments. 
Methanotrophs have been the subject of 
increasing interest because they can use 
methane as a sole source of carbon and 
energy—which means they play a major 
role in global carbon cycles—and could 
dramatically reduce biologically generated 
methane emissions. They’ve also been the 
focus of bioremediation efforts aimed at 
environmental decontamination. And now, 
with the publication of the ﬁ  rst complete 
genome sequence of a methanotroph, 
such efforts will be all the easier. In this 
issue of PLoS Biology, a multidisciplinary 
team spanning the ﬁ  elds of genomics, 
bioinformatics, microbiology, evolutionary 
biology, and molecular biology report 
the complete genome sequence of 
Methylococcus capsulatus and shed light 
on the metabolism and biology of this 
ubiquitous microbe. 
Contained in a single, circular molecule, 
the M. capsulatus genome comprises 
about 3.3 million base pairs—which 
is about average for a free-living 
bacterium—with an estimated 3,120 
genes. The genome appears well-
equipped to meet the specialized needs 
of this methanotroph, with what appear 
to be multiple pathways involved in the 
metabolism of methane and duplications 
of genes that code for methane 
monooxygenases, which are essential for 
the ﬁ  rst step of methane oxidation. 
Ward et al. also found evidence of 
“genomic redundancy” in methane 
oxidation pathways, suggesting 
that M. capsulatus employs different 
pathways depending on the availability 
of molecules needed to sustain 
cellular activities. Most surprising, the 
researchers note, was evidence that this 
methane specialist can turn into a sort 
of metabolic generalist—with a capacity 
to use sugars, hydrogen, and sulfur—and 
appears able to survive reduced oxygen 
levels. These genome-based hypotheses 
will require experimental validation, the 
authors note, but could have important 
implications for M. capsulatus ecology—
including what environments might be 
amenable to methanotroph-mediated 
bioremediation. 
The genomes of important microbial 
players in the carbon cycle—including 
microbes involved in photosynthesis 
and methanogenesis (methane 
production)—have already been 
sequenced. With the addition of a 
sequenced methanotroph genome, 
scientists can systematically investigate 
different genes and regulatory elements 
to better understand how these methane 
consumers ﬁ  t into this global cycle. 
The M. capsulatus genome provides a 
platform for investigating the details of 
methanotroph biology and its potential 
as a biotech workhorse. It may also 
guide efforts to harness this bacterium’s 
penchant for methane to reduce global 
greenhouse gas emissions, to degrade 
chlorinated hydrocarbons and other 
persistent pollutants, and to produce 
protein for animal feed.
Ward N, Larsen Ø, Sakwa J, Bruseth L, 
Khouri H, et al. (2004) Genomic insights 
into methanotrophy: The complete genome 
sequence of Methylococcus capsulatus (Bath). 
DOI: 10.1371/journal.pbio.0020303
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A Molecular Model of Blood Cell Renewal
DOI: 10.1371/journal.pbio.0020349
A developing organism captured on time-lapse video is a wonder to behold. If you’re 
watching a chick embryo, by day 3, you’ll see millions of cells engaged in a frenzy of 
activity, as rapidly dividing cells migrate to new positions, acquire the characteristics 
of specialized cells, and craft well-deﬁ  ned tissues, organs, and limbs in just under two 
weeks. In addition to the cells destined for specialization is another important group, 
stem cells, whose progeny have two very different fates. They can either  “self renew”—
that is, make identical copies of themselves—or generate intermediate progenitor cells 
that give rise to mature, differentiated cells. 
Both differentiation and self renewal are guided by an elaborately regulated genetic 
program, which transforms embryonic stem cells into the many different cell types 
that make up the body. Adult stem cells share the hallmark trait of self renewal, but are 
relatively rare: in bone marrow, the source of hematopoietic, or blood-forming, only an 
estimated one in 10,000–    15,000 cells is an adult hematopoietic stem cell (HSC).
 Studies that have compared the gene expression proﬁ  les of different types of stem 
cells to identify genetic signatures of “stemness” have found only a limited number of 
signature genes. And the molecular mechanisms that regulate this so-called potency 
and the self renewal process have remained obscure. Now, focusing on HSCs, Margaret 
Goodell and colleagues have undertaken a systematic evaluation of HSC renewal. The 
study identiﬁ  es molecular signatures associated with discrete stages of the HSC self 
renewal cycle and proposes a molecular model of the process.
HSC renewal passes through three stages: quiescence, activation and proliferation, 
and a return to the dormant state. HSCs give rise to both red blood cells, which 
carry oxygen and carbon dioxide, and white blood cells, which ﬁ  ght infection. 
Certain stressors—including blood-cell-inhibiting chemotherapy and bone marrow 
transplants—trigger HSC activation, which induces rapid proliferation, generating both 
progenitors to deal with the threat and new stem cells that return to quiescence. Once 
activated by a trigger, dormant HSCs engage a regulatory program that rapidly churns 
out billions of cells, then puts the brakes on cell division, prompting the return to a 
nondividing, quiescent state.
To understand the genetic programs underlying this process, Goodell and colleagues 
induced proliferation in HSCs (with the chemotherapeutic drug, 5-ﬂ  uorouracil, or 5FU), 
then allowed the cells to return to quiescence, so they could characterize the changes 
in gene expression that occurred during each stage. They compared these time-speciﬁ  c 
patterns to the gene expression proﬁ  les of naturally proliferating fetal mouse HSCs 
(which undergo massive proliferation) and quiescent adult mouse HSCs (which hardly 
divide at all) to ﬁ  nd genes associated with the two different states. 
Genes were grouped into proliferating or quiescent groups based on when they were 
expressed after 5FU treatment, and these groupings were reﬁ  ned based on comparisons 
to previously published HSC gene expression data. Functional analysis of these genes 
found a bias toward genes involved in cell division processes in the proliferation stage 
and toward cell division inhibitors in the quiescent stage, supporting the logic of the 
groupings. To understand the activation process at a global level, the authors employed 
some novel analysis strategies, including the “Gene Ontology” (GO) system for classifying 
genes. 
With these results, Goodell and colleagues constructed a model of the HSC self 
renewal cycle: quiescent HSCs maintain a “state of readiness,” molecularly speaking, that 
allows a quick response to environmental triggers. A stressor (like the chemotherapy 
mentioned above) triggers a “prepare to proliferate” state—a kind of pregnant pause—
and then the proliferation machinery kicks in, going through an early and late phase 
before quiescence returns. By shedding light on the molecular mechanisms of stem cell 
renewal, this study will aid efforts to develop stem-cell-based clinical therapies, which 
depend on replicating the HSC self renewal cycle to replenish diseased or damaged 
tissue, and will ultimately guide efforts to grow stem cell colonies outside the body, a 
long-standing goal that would have many clinical applications. The authors suggest 
their ﬁ  ndings may also be relevant to studies of cancer stem cells, tumor cells with self 
renewal properties.
Venezia TA, Merchant AA, Ramos CA, Whitehouse NL, Young AS, et al. (2004) Molecular 
signatures of proliferation and quiescence in hematopoietic stem cells. DOI: 10.1371/journal.
pbio.0020301
We Move in Mysterious Ways
DOI: 10.1371/journal.pbio.0020370
A man in a suit and bowler hat walks 
awkwardly down the street, each 
convoluted step a labored movement. 
He lifts up one knee, then brieﬂ  y stoops. 
Stepping forward, he swings the other 
leg out to the side then kicks high in the 
air. In this old Monty Python skit, the man 
works for the Ministry of Silly Walks. It’s 
his job to walk this way. The rest of us, 
however, tend to stroll along—or throw 
baseballs, or lift coffee mugs—in a much 
more efﬁ  cient manner.
There’s a nearly inﬁ  nite number of silly 
walks, throws, and lifts, but somehow 
people tend to settle on one best 
way of doing these things. However, 
scientists studying motor control have 
been hard pressed to ﬁ  gure out what 
exactly we’re doing when we move. 
People may be striking a balance 
between sloth and speed: too slow and 
our throws lack oomph; too fast, and 
instead of dunking our donuts in our 
coffee, we dunk our whole ﬁ  st. Or people 
might be minimizing some version of 
jerk—physicists’ and engineers’ term for 
changes in acceleration. (Roller coaster 
engineers, for example, balance jerk 
against speed and g’s to keep the ride 
smooth and safe, but also fun.) But so 
far, such models that start by assuming 
people minimize error or jerk haven’t 
allowed researchers to deduce what 
dictates how people move.
To help solve this recalcitrant problem, 
Konrad Körding and colleagues, as 
reported in PLoS Biology, took a page 
from economists, who have long used 
equations called utility functions that 
incorporate the costs and beneﬁ  ts of 
a situation. Say you like oranges better 
than apples, but oranges cost more. 
Given a certain budget for fruit, the 
utility function says how many of each 
you should buy. Similarly, Körding and 
colleagues observed people’s preferred 
movements, then inferred an underlying 
utility function that presumably describes 
bias in the nervous system for different 
movements.
To see which movements people 
preferred, the researchers engaged 
people in a simple virtual reality system. 
The subjects moved a joystick that fought 
back: it was connected to a set of motors 
that produced varying forces—with a 
strong force for a short time, say, or a mild 
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A Test Case for DNA Barcodes 
to Identify Species
DOI: 10.1371/journal.pbio.0020357
One hundred years before Darwin 
returned from his voyage on the H. M. 
S. Beagle “struck with certain facts” that 
“seemed to throw some light on the 
origin of species,” Linnaeus published 
the ﬁ  rst systematic taxonomy of life. In 
Systema Naturae, the Swedish botanist 
divided organisms into plants, animals, 
and minerals, eventually assigning 
scientiﬁ  c names to 7,700 plant and 4,400 
animal species, and popularizing the 
binomial system—as in Homo sapiens—
of naming species. 
In the 1700s and 1800s, naturalists 
classiﬁ  ed organisms based on 
morphology, devoting their careers to 
naming newfound plants and animals. 
Today biologists still use Linnaean 
taxonomy as the foundation of scientiﬁ  c 
classiﬁ  cation. But with just a fraction of 
the estimated 5  –30 million species on 
the planet already named and too few 
specialists to do the job, biologists are 
looking for high-throughput tools that 
can rapidly and accurately identify both 
individuals of a species and entirely 
new species. That’s what some scientists 
say the DNA barcode will do. The DNA 
barcode, as the name implies, uses genes 
to identify species much like supermarket 
barcodes identify products. The idea is 
that a short stretch of genetic code from 
a reference gene is unique enough to 
one species to distinguish it from every 
other species, and that comparisons 
of sequence variations in that stretch 
of gene can reveal evolutionary 
relationships among species.
Such technology could radically 
advance biologists’ attempts to achieve 
the long-standing goal of cataloging 
life on earth, but the approach is 
controversial, with critics questioning 
both the method and its applications. 
(For more on the debate, see “DNA 
Barcoding: Promise and Pitfalls,” also in 
this issue.) Paul Hebert and colleagues 
offer a proof of the utility of the DNA 
barcoding concept, using a 648-
basepair region of a mitochondrial gene 
(cytochrome c oxidase I, or COI) in a study 
of 260 North American bird species.
Mitochondria—the cell’s power 
generators—contain their own DNA, and 
mitochondrial DNA (mtDNA) evolves 
much faster than nuclear DNA. It evolves 
so quickly, in fact, that mtDNA sequence 
variation has been found not just 
between closely related, or sister, species 
but also within species. Still, the variation 
is much greater among than within 
species, which is why mtDNA divergences 
have become a tool for identifying 
species. 
Hebert and colleagues tested the 
effectiveness of the mtDNA COI barcode 
by matching bird species ﬂ  agged by 
the COI barcode against those already 
established by taxonomic methods. The 
litmus test for DNA barcoding is absence 
of COI sequence overlap between 
species. Beyond that, differences within 
species should be signiﬁ  cantly fewer than 
those between species. And that’s what 
the researchers found. All 260 species had 
unique COI barcodes, with differences 
between species for the most part much 
more frequent—on average, 18 times 
more common—than those within 
species. In the 130 species represented by 
two or more individuals, COI sequences 
were either identical or closest to other 
sequences within that species. For these 
260 bird species (of the 667 bird species 
that breed in North America), the authors 
report, the COI barcodes “separate 
individuals into the categories that 
taxonomists call species.” 
The COI barcode, the authors 
propose, could help resolve problematic 
classiﬁ  cations based on morphology, 
as arise when populations of a single 
species acquire distinct characteristics 
after geographic barriers prevent their 
interbreeding. For example, the similar 
COI sequences found in American and 
black oystercatchers here support 
taxonomic studies suggesting that they 
are actually color morphs of one species. 
And conversely, highly divergent COI 
sequences might bolster taxonomic 
studies indicating that lineages of 
uncertain status are indeed distinct 
species. 
Future studies will have to determine 
whether these results can be 
generalized to animals in other climes 
and ecosystems, but the authors argue 
that constructing a comprehensive 
library of barcodes will facilitate 
such efforts. Hebert and colleagues 
conclude that the success of DNA 
barcoding depends not only on such a 
repository—with sequences pegged to 
well-characterized species exemplars—
but also on the expertise of trained 
taxonomists. The hope is that large-scale, 
standardized testing based on a uniform 
barcode sequence could go a long 
way toward ﬁ  nishing what Linnaeus 
started: a full classiﬁ  cation of all plant 
and animal life. To E. O. Wilson, every 
species is “a masterpiece of evolution, 
offering a vast source of useful scientiﬁ  c 
knowledge because it is so thoroughly 
adapted to the environment in which 
it lives.” Faced with what Wilson calls 
the “worst wave of extinction since the 
dinosaurs died,” the need for a fast and 
easy way to identify species has never 
been greater.
Hebert PDN, Stoeckle MY, Zemlak TS, 
Francis CM (2004) Identiﬁ  cation of birds 
through DNA barcodes. DOI: 10.1371/
journal.pbio.0020312
force for a longer time. Over and over, the 
subjects moved their cursors from one 
spot to another. After each pair of moves, 
the subjects then chose which of the two 
movements they found easier.
In this way, the researchers were able 
to rank a large set of different movements 
relative to each other by individuals’ 
preferences. They found a surprising 
amount of agreement among the subjects 
on which movements were preferable. 
They also got a counterintuitive result: 
as the duration of the resistance got 
longer, people actually preferred stronger 
resistance. The researchers speculate that 
subjects didn’t mind larger resistance 
when it acted over a longer period 
because the force takes longer to ramp 
up to its maximum value. Subjects would 
have more time to adjust—just as when 
someone gradually pushes into you, you 
can stay standing by leaning into them, 
whereas if they shove you with the same 
force it can knock you off balance.
By showing that utility functions can 
be of use not only in explaining the 
marketplace but also motor control, 
Körding and colleagues have added a 
new tool to biologists’ repertoire. Though 
their approach hasn’t closed the case on 
the mysteries of movement, it could help 
explain why we settle for a particular, 
non-silly walk.
Körding KP, Fukunaga I, Howard I, Ingram 
J, Wolpert DM (2004) A neuroeconomics 
approach to inferring utility functions 
in sensorimotor control.  DOI: 10.1371/
journal.pbio.0020330
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How to Make a Mother in Five Easy Steps
DOI: 10.1371/journal.pbio.0020359
Assembling a complex structure like an automobile requires 
the tight coordination of hundreds of independent entities—
parts must be shipped and arrive on time, workers with the 
right skills must be in the right place on the assembly line, four 
(not three, not ﬁ  ve) wheels must be bolted into place just so. 
Overseeing the entire operation is a cadre of managers, whose 
ability to monitor and respond to changing conditions keeps the 
entire process moving forward on time and in step.
A living cell is orders of magnitude more complex, and yet 
has no omniscient manager at the 
helm. So how does a cell make 
anything happen on time, and equally 
important, keep everything from 
happening all at once? These central 
questions in developmental biology 
now have the outlines of an answer 
in one species, Bacillus subtilis. In this 
issue, Richard Losick and colleagues 
show that spore formation in this 
bacterium is ultimately governed 
by the temporal interactions of ﬁ  ve 
genes, which together coordinate the 
activity of almost 400 others.
When conditions are right, B. subtilis 
divides to form two different cell 
types: one is a resistant spore, and the 
other is a mother cell, which engulfs 
the spore and surrounds it with a 
protective coat. Building on the large 
literature addressing the genetic events underlying mother-cell 
development, Losick et al. performed a variety of experiments 
to determine exactly which genes turned on and off when, and 
which genes controlled which others. Over the ﬁ  ve-hour process 
of mother-cell development, they determined that 383 individual 
genes were activated, representing 9% of the bacterium’s 4,106 
genes.
The instigator of the entire process is a protein called sigma-
E (σE). Sigma factors, such as the sigma-E protein, bind to 
RNA polymerase, and in so doing, increase its afﬁ  nity for, and 
therefore its ability to activate, other genes. Thus, sigma factors 
preferentially activate a speciﬁ  c set of genes. Sigma-E turns on 
262 genes (which together compose its “regulon”), kick-starting a 
variety of processes in the early development of the mother cell. 
Importantly, two of its targets, SpoIIID and GerR, are genes 
for DNA-binding proteins, which themselves modulate the 
expression of genes in the middle phase of development. Part of 
SpoIIID’s portfolio is turning off transcription of a portion of the 
sigma-E regulon, and amplifying transcription of another portion. 
This type of control circuit, in which A leads to B, and then both A 
and B inﬂ  uence C, is called a feed-forward loop. 
Among the joint targets for sigma-E and SpoIIID is another 
sigma factor, sigma-K (σK). By generating the DNA-binding 
protein GerE, this factor begins a second feed-forward loop, 
and together, sigma-K and GerE activate the ﬁ  nal set of genes 
needed for mother-cell development. 
In outline, the system looks like this: 
sigma-E   SpoIIID/GerR   sigma-K 
  GerE.
The consequence of all this activity 
is a series of transcriptional pulses, 
timed to supply proteins just as they 
are needed, and then turn off their 
production when the need passes. 
For instance, to form the multilayered 
coat around the spore, sigma-E turns 
on genes that form the bottom layer, 
or substratum; these are turned off 
by SpoIIID. Genes for outer layers, also 
turned on by sigma-E, are not turned 
off by SpoIIID, but instead by GerE. 
Sigma-K turns on genes which form 
the polysaccharide surface of the 
coat, which is needed later on.
The elucidation of this complex 
pattern of gene expression doesn’t by any means answer every 
question about B. subtilis development, let alone development 
in more complex organisms. There is much still to be learned 
about how genes lower down in the hierarchy—the “middle 
managers”—do their jobs, and how the system is ﬁ  ne-tuned 
by environmental conditions. And while the general scheme of 
feed-forward loops and hierarchical control is likely to apply to 
multicellular, eukaryotic organisms, the details are certain to be 
different, and much more complex. 
Eichenberger P, Fujita M, Jensen ST, Conlon EM, Rudner DZ, et al. 
(2004) The program of gene transcription for a single differentiating 
cell type during sporulation in Bacillus subtilis. DOI: 10.1371/journal.
pbio.0020328
DOI: 10.1371/journal.pbio.0020359.g001
A pair of Bacillus subtilis sporangia, consisting of a 
large mother cell (green) and a forespore (red)
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